Sign in to see private stats on your profile page — or add photo, interests, videos, mentoring, etc.

    Olga Momcilovic, PhD

    TitleAssistant Researcher
    SchoolUCSF School of Dentistry
    DepartmentCell and Tissue Biology
    Address513 Parnassus Ave
    San Francisco CA 94143
    vCardDownload vCard

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Horiuchi D, Camarda R, Zhou AY, Yau C, Momcilovic O, Balakrishnan S, Corella AN, Eyob H, Kessenbrock K, Lawson DA, Marsh LA, Anderton BN, Rohrberg J, Kunder R, Bazarov AV, Yaswen P, McManus MT, Rugo HS, Werb Z, Goga A. PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression. Nat Med. 2016 Nov; 22(11):1321-1329. PMID: 27775705.
        View in: PubMed
      2. Momcilovic O, Sivapatham R, Oron TR, Meyer M, Mooney S, Rao MS, Zeng X. Derivation, Characterization, and Neural Differentiation of Integration-Free Induced Pluripotent Stem Cell Lines from Parkinson's Disease Patients Carrying SNCA, LRRK2, PARK2, and GBA Mutations. PLoS One. 2016; 11(5):e0154890. PMID: 27191603.
        View in: PubMed
      3. Wang ES, Reyes NA, Melton C, Huskey NE, Momcilovic O, Goga A, Blelloch R, Oakes SA. Fas-Activated Mitochondrial Apoptosis Culls Stalled Embryonic Stem Cells to Promote Differentiation. Curr Biol. 2015 Dec 7; 25(23):3110-8. PMID: 26585277.
        View in: PubMed
      4. Shaltouki A, Sivapatham R, Pei Y, Gerencser AA, Momcilovic O, Rao MS, Zeng X. Mitochondrial alterations by PARKIN in dopaminergic neurons using PARK2 patient-specific and PARK2 knockout isogenic iPSC lines. Stem Cell Reports. 2015 May 12; 4(5):847-59. PMID: 25843045; PMCID: PMC4437475.
      5. Huskey NE, Guo T, Evason KJ, Momcilovic O, Pardo D, Creasman KJ, Judson RL, Blelloch R, Oakes SA, Hebrok M, Goga A. CDK1 inhibition targets the p53-NOXA-MCL1 axis, selectively kills embryonic stem cells, and prevents teratoma formation. Stem Cell Reports. 2015 Mar 10; 4(3):374-89. PMID: 25733019; PMCID: PMC4375943.
      6. Momcilovic O, Liu Q, Swistowski A, Russo-Tait T, Zhao Y, Rao MS, Zeng X. Genome wide profiling of dopaminergic neurons derived from human embryonic and induced pluripotent stem cells. Stem Cells Dev. 2014 Feb 15; 23(4):406-20. PMID: 24074155; PMCID: PMC3920839.
      7. Momcilovic O, Montoya-Sack J, Zeng X. Dopaminergic differentiation using pluripotent stem cells. J Cell Biochem. 2012 Dec; 113(12):3610-9. PMID: 22807388.
        View in: PubMed
      8. Varum S, Rodrigues AS, Moura MB, Momcilovic O, Easley CA, Ramalho-Santos J, Van Houten B, Schatten G. Energy metabolism in human pluripotent stem cells and their differentiated counterparts. PLoS One. 2011; 6(6):e20914. PMID: 21698063; PMCID: PMC3117868.
      9. Momcilovic O, Navara C, Schatten G. Cell cycle adaptations and maintenance of genomic integrity in embryonic stem cells and induced pluripotent stem cells. Results Probl Cell Differ. 2011; 53:415-58. PMID: 21630155.
        View in: PubMed
      10. Momcilovic O, Knobloch L, Fornsaglio J, Varum S, Easley C, Schatten G. DNA damage responses in human induced pluripotent stem cells and embryonic stem cells. PLoS One. 2010; 5(10):e13410. PMID: 20976220; PMCID: PMC2955528.
      11. Varum S, Momcilovic O, Castro C, Ben-Yehudah A, Ramalho-Santos J, Navara CS. Enhancement of human embryonic stem cell pluripotency through inhibition of the mitochondrial respiratory chain. Stem Cell Res. 2009 Sep-Nov; 3(2-3):142-56. PMID: 19716358; PMCID: PMC2837416.
      12. Momcilovic O, Choi S, Varum S, Bakkenist C, Schatten G, Navara C. Ionizing radiation induces ataxia telangiectasia mutated-dependent checkpoint signaling and G(2) but not G(1) cell cycle arrest in pluripotent human embryonic stem cells. Stem Cells. 2009 Aug; 27(8):1822-35. PMID: 19544417; PMCID: PMC3340923.
      13. Popovic V, Arandelovic M, Jovanovic J, Momcilovic O, Veselic E, Dordevic D, Popovic A, Todorovska D. [The effect of occupational noxae in the tobacco industry on pulmonary function in exposed workers]. Arh Hig Rada Toksikol. 1992 Mar; 43(1):37-45. PMID: 1510615.
        View in: PubMed
      14. Popovic V, Arandelovic M, Jovanovic J, Veselic E, Popovic A, Momcilovic O, Ilic D. [The effect of occupational exposure to respiratory noxae in the tobacco industry on the status of pulmonary ventilation]. Plucne Bolesti. 1991 Jan-Jun; 43(1-2):51-4. PMID: 1766987.
        View in: PubMed
      15. Popovic V, Arandelovic M, Vracevic M, Popovic M, Momcilovic O, Ilic D, Jovanovic J, Jakubi S. [Characteristics of the ventilatory status of the lungs in workers in the electronics industry]. Arh Hig Rada Toksikol. 1990 Mar; 41(1):35-46. PMID: 2396898.
        View in: PubMed
      16. Popovic V, Jovanovic J, Todorovic R, Arandelovic M, Momcilovic O, Dordevic D. [Results of bronchodilation tests in workers exposed to occupation respiratory noxae]. Plucne Bolesti. 1990 Jan-Jun; 42(1-2):100-3. PMID: 2217618.
        View in: PubMed
      17. Popovic V, Arandelovic M, Popovic M, Vracevic M, Ilic D, Jakubi S, Markovic L, Momcilovic O, Todorovska D. [The effect of harmful chemicals used in the electronics industry on airflow resistance in the respiratory tract]. Plucne Bolesti. 1989 Jul-Dec; 41(3-4):157-61. PMID: 2636397.
        View in: PubMed
      18. Popovic V, Trickovic K, Jovanovic J, Arandelovic M, Popovic M, Momcilovic O, Veselic E, Ilic D, Jakubi S, Markovic L. [The effect of occupational damage registered in the metalworking industry on the basis of pulmonary function in workers]. Arh Hig Rada Toksikol. 1988 Jun; 39(2):203-13. PMID: 3223818.
        View in: PubMed
      Olga's Networks
      Related Concepts
      Derived automatically from this person's publications.
      People in Profiles who have published with this person.
      Related Authors
      People who share related concepts with this person.
      Back to TOP